• atrial
  • They sense atrial or ventricular electrical activity, classify these signals to various programmed "heart rate zones," deliver tiered therapies to terminate ventricular tachycardia or fibrillation, and pace for bradycardia. (apsf.org)
  • device
  • Systems are implanted by testing external or implantable devices at different tissue sites, observing physiologic and device responses, and selecting sites with preferred performance for implanting the systems. (google.es)
  • An implantable medical device and associated method for automatically generating morphology templates during fast cardiac rhythms, confirming a provisional template as a confirmed template, and using the confirmed template to classify subsequent detected arrhythmias. (google.com)
  • Systems and methods provide for detecting, using an implantable device or a patient-external device, patient respiration and computing a respiration rate based on the detected patient respiration. (google.com)
  • Retrospective risk adjusted data indicate that attempted antibiotic therapy without device removal during the initial treatment is associated with increased 1-year mortality compared to prompt device removal early during the initial course of antibiotic therapy. (oncologynurseadvisor.com)
  • P-related risk factors include age, chronic steroid therapy, anticoagulation (predisposing patients to post-implantation pocket hematoma), diabetes mellitus, heart failure, renal failure, immunosuppressive therapy, or presence of a central venous catheter (risk factor for bacteremia and subsequent device seeding) are the most significant predisposing conditions. (oncologynurseadvisor.com)
  • rhythms
  • Some external units, known as automated external defibrillators (AEDs), automate the diagnosis of treatable rhythms, meaning that lay responders or bystanders are able to use them successfully with little or no training. (wikipedia.org)
  • System
  • 4. The system according to claim 1 , further comprising an implantable pharmacological agent reservoir within the can. (google.com.au)
  • 10. The system according to claim 1 , further comprising a controller configured to coordinate phoresis delivery of the pharmacological agent relative to electrical cardiac stimulation therapy such that the driving arrangement facilitates phoresis delivery of the pharmacological agent after delivery of electrical cardiac stimulation therapy. (google.com.au)